1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on CHA Industry 1.7 COVID-19 Impact: CHA Market Trends 2 Global CHA Quarterly Market Size Analysis 2.1 CHA Business Impact Assessment - COVID-19 2.1.1 Global CHA Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global CHA Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global CHA Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global CHA Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global CHA Factory Price by Manufacturers 3.3 Location of Key Manufacturers CHA Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into CHA Market 3.5 Key Manufacturers CHA Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on CHA Segments, By Type 4.1 Introduction 1.4.1 Cosmetics Grade 1.4.2 Pharmaceutical Grade 4.2 By Type, Global CHA Market Size, 2019-2021 4.2.1 By Type, Global CHA Market Size by Type, 2020-2021 4.2.2 By Type, Global CHA Price, 2020-2021 5 Impact of Covid-19 on CHA Segments, By Application 5.1 Overview 5.5.1 Cosmetics Additives 5.5.2 Pharmaceutical Intermediates 5.2 By Application, Global CHA Market Size, 2019-2021 5.2.1 By Application, Global CHA Market Size by Application, 2019-2021 5.2.2 By Application, Global CHA Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 Carbone scientific 7.1.1 Carbone scientific Business Overview 7.1.2 Carbone scientific CHA Quarterly Production and Revenue, 2020 7.1.3 Carbone scientific CHA Product Introduction 7.1.4 Carbone scientific Response to COVID-19 and Related Developments 7.2 Ark Pharm 7.2.1 Ark Pharm Business Overview 7.2.2 Ark Pharm CHA Quarterly Production and Revenue, 2020 7.2.3 Ark Pharm CHA Product Introduction 7.2.4 Ark Pharm Response to COVID-19 and Related Developments 7.3 Hangzhou Lingeba Technology 7.3.1 Hangzhou Lingeba Technology Business Overview 7.3.2 Hangzhou Lingeba Technology CHA Quarterly Production and Revenue, 2020 7.3.3 Hangzhou Lingeba Technology CHA Product Introduction 7.3.4 Hangzhou Lingeba Technology Response to COVID-19 and Related Developments 7.4 TCI 7.4.1 TCI Business Overview 7.4.2 TCI CHA Quarterly Production and Revenue, 2020 7.4.3 TCI CHA Product Introduction 7.4.4 TCI Response to COVID-19 and Related Developments 7.5 Wuhan 3B Scientific Corporation 7.5.1 Wuhan 3B Scientific Corporation Business Overview 7.5.2 Wuhan 3B Scientific Corporation CHA Quarterly Production and Revenue, 2020 7.5.3 Wuhan 3B Scientific Corporation CHA Product Introduction 7.5.4 Wuhan 3B Scientific Corporation Response to COVID-19 and Related Developments 7.6 HBCChem 7.6.1 HBCChem Business Overview 7.6.2 HBCChem CHA Quarterly Production and Revenue, 2020 7.6.3 HBCChem CHA Product Introduction 7.6.4 HBCChem Response to COVID-19 and Related Developments 7.7 Sichuan Nanbu Honest and Creditable Science-tech Ltd 7.7.1 Sichuan Nanbu Honest and Creditable Science-tech Ltd Business Overview 7.7.2 Sichuan Nanbu Honest and Creditable Science-tech Ltd CHA Quarterly Production and Revenue, 2020 7.7.3 Sichuan Nanbu Honest and Creditable Science-tech Ltd CHA Product Introduction 7.7.4 Sichuan Nanbu Honest and Creditable Science-tech Ltd Response to COVID-19 and Related Developments 7.8 BePharm Ltd 7.8.1 BePharm Ltd Business Overview 7.8.2 BePharm Ltd CHA Quarterly Production and Revenue, 2020 7.8.3 BePharm Ltd CHA Product Introduction 7.8.4 BePharm Ltd Response to COVID-19 and Related Developments 7.9 Yolne reagent 7.9.1 Yolne reagent Business Overview 7.9.2 Yolne reagent CHA Quarterly Production and Revenue, 2020 7.9.3 Yolne reagent CHA Product Introduction 7.9.4 Yolne reagent Response to COVID-19 and Related Developments 7.10 Aladdin 7.10.1 Aladdin Business Overview 7.10.2 Aladdin CHA Quarterly Production and Revenue, 2020 7.10.3 Aladdin CHA Product Introduction 7.10.4 Aladdin Response to COVID-19 and Related Developments 7.11 Hunan Hecheng 7.11.1 Hunan Hecheng Business Overview 7.11.2 Hunan Hecheng CHA Quarterly Production and Revenue, 2020 7.11.3 Hunan Hecheng CHA Product Introduction 7.11.4 Hunan Hecheng Response to COVID-19 and Related Developments 7.12 Beijing Yunbang Biosciences 7.12.1 Beijing Yunbang Biosciences Business Overview 7.12.2 Beijing Yunbang Biosciences CHA Quarterly Production and Revenue, 2020 7.12.3 Beijing Yunbang Biosciences CHA Product Introduction 7.12.4 Beijing Yunbang Biosciences Response to COVID-19 and Related Developments 7.13 Inolex 7.13.1 Inolex Business Overview 7.13.2 Inolex CHA Quarterly Production and Revenue, 2020 7.13.3 Inolex CHA Product Introduction 7.13.4 Inolex Response to COVID-19 and Related Developments 7.14 9Dingchem 7.14.1 9Dingchem Business Overview 7.14.2 9Dingchem CHA Quarterly Production and Revenue, 2020 7.14.3 9Dingchem CHA Product Introduction 7.14.4 9Dingchem Response to COVID-19 and Related Developments 7.15 Chen Hson Holding Limited 7.15.1 Chen Hson Holding Limited Business Overview 7.15.2 Chen Hson Holding Limited CHA Quarterly Production and Revenue, 2020 7.15.3 Chen Hson Holding Limited CHA Product Introduction 7.15.4 Chen Hson Holding Limited Response to COVID-19 and Related Developments 7.16 Yancheng Langde Chemical & Pharmaceutical 7.16.1 Yancheng Langde Chemical & Pharmaceutical Business Overview 7.16.2 Yancheng Langde Chemical & Pharmaceutical CHA Quarterly Production and Revenue, 2020 7.16.3 Yancheng Langde Chemical & Pharmaceutical CHA Product Introduction 7.16.4 Yancheng Langde Chemical & Pharmaceutical Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 CHA Supply Chain Analysis 8.1.1 CHA Supply Chain Analysis 8.1.2 Covid-19 Impact on CHA Supply Chain 8.2 Distribution Channels Analysis 8.2.1 CHA Distribution Channels 8.2.2 Covid-19 Impact on CHA Distribution Channels 8.2.3 CHA Distributors 8.3 CHA Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on CHA Assessment Table 9. COVID-19 Impact: CHA Market Trends Table 10. COVID-19 Impact Global CHA Market Size Table 11. Global CHA Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT) Table 12. Global CHA Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT) Table 13. Global CHA Quarterly Market Size, 2020 (US$ Million) & (K MT) Table 14. Global CHA Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global CHA Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT) Table 16. Global CHA Market Growth Drivers Table 17. Global CHA Market Restraints Table 18. Global CHA Market Opportunities Table 19. Global CHA Market Challenges Table 20. Key Manufacturers CHA Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, CHA Market Size, 2019 (K MT) & (US$ Million) Table 22. CHA Factory Price by Manufacturers 2020 (USD/MT) Table 23. Location of Key Manufacturers CHA Manufacturing Plants Table 24. Key Manufacturers CHA Market Served Table 25. Date of Key Manufacturers Enter into CHA Market Table 26. Key Manufacturers CHA Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global CHA Market Size by Type, 2020, (US$ Million) Table 29. Global CHA Market Size by Type, 2020 (K MT) Table 30. Global CHA Price: by Type, 2020-2021 (USD/MT) Table 31. Global CHA Market Size by Application: 2020-2021 (US$ Million) Table 32. Global CHA Market Size by Application, 2020-2021 (K MT) Table 33. Global CHA Price: by Application, 2020-2021 (USD/MT) Table 34. Global CHA Market Size by Region, 2019-2021 (US$ Million) Table 35. Global CHA Market Size by Region, 2019-2021 (K MT) Table 36. By Country, North America CHA Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America CHA Market Size, 2019-2021 (K MT) Table 38. US CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 39. Canada CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe CHA Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe CHA Market Size, 2019-2021 (K MT) Table 43. Germany CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 44. France CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 45. UK CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 46. Italy CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific CHA Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific CHA Market Size, 2019-2021 (K MT) Table 50. China CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 51. Japan CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 52. South Korea CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 53. India CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 54. ASEAN CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 55. Latin America CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 56. Middle East and Africa CHA Market Size, 2019-2021 (US$ Million) & (K MT) Table 57. Carbone scientific Business Overview Table 58. Carbone scientific CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. Carbone scientific CHA Product Table 60. Carbone scientific Response to COVID-19 and Related Developments Table 61. Ark Pharm Business Overview Table 62. Ark Pharm CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Ark Pharm CHA Product Table 64. Ark Pharm Response to COVID-19 and Related Developments Table 65. Hangzhou Lingeba Technology Business Overview Table 66. Hangzhou Lingeba Technology CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Hangzhou Lingeba Technology CHA Product Table 68. Hangzhou Lingeba Technology Response to COVID-19 and Related Developments Table 69. TCI Business Overview Table 70. TCI CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. TCI CHA Product Table 72. TCI Response to COVID-19 and Related Developments Table 73. Wuhan 3B Scientific Corporation Business Overview Table 74. Wuhan 3B Scientific Corporation CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Wuhan 3B Scientific Corporation CHA Product Table 76. Wuhan 3B Scientific Corporation Response to COVID-19 and Related Developments Table 77. HBCChem Business Overview Table 78. HBCChem CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. HBCChem CHA Product Table 80. HBCChem Response to COVID-19 and Related Developments Table 81. Sichuan Nanbu Honest and Creditable Science-tech Ltd Business Overview Table 82. Sichuan Nanbu Honest and Creditable Science-tech Ltd CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Sichuan Nanbu Honest and Creditable Science-tech Ltd CHA Product Table 84. Sichuan Nanbu Honest and Creditable Science-tech Ltd Response to COVID-19 and Related Developments Table 85. BePharm Ltd Business Overview Table 86. BePharm Ltd CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. BePharm Ltd CHA Product Table 88. BePharm Ltd Response to COVID-19 and Related Developments Table 89. Yolne reagent Business Overview Table 90. Yolne reagent CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Yolne reagent CHA Product Table 92. Yolne reagent Response to COVID-19 and Related Developments Table 93. Aladdin Business Overview Table 94. Aladdin CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Aladdin CHA Product Table 96. Aladdin Response to COVID-19 and Related Developments Table 97. Hunan Hecheng Business Overview Table 98. Hunan Hecheng CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Hunan Hecheng CHA Product Table 100. Hunan Hecheng Response to COVID-19 and Related Developments Table 101. Beijing Yunbang Biosciences Business Overview Table 102. Beijing Yunbang Biosciences CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. Beijing Yunbang Biosciences CHA Product Table 104. Beijing Yunbang Biosciences Response to COVID-19 and Related Developments Table 105. Inolex Business Overview Table 106. Inolex CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 107. Inolex CHA Product Table 108. Inolex Response to COVID-19 and Related Developments Table 109. 9Dingchem Business Overview Table 110. 9Dingchem CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 111. 9Dingchem CHA Product Table 112. 9Dingchem Response to COVID-19 and Related Developments Table 113. Chen Hson Holding Limited Business Overview Table 114. Chen Hson Holding Limited CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 115. Chen Hson Holding Limited CHA Product Table 116. Chen Hson Holding Limited Response to COVID-19 and Related Developments Table 117. Yancheng Langde Chemical & Pharmaceutical Business Overview Table 118. Yancheng Langde Chemical & Pharmaceutical CHA Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 119. Yancheng Langde Chemical & Pharmaceutical CHA Product Table 120. Yancheng Langde Chemical & Pharmaceutical Response to COVID-19 and Related Developments Table 121. CHA Distributors List Table 122. CHA Customers List Table 123. Covid-19 Impact on CHA Customers List of Figures Figure 1. CHA Product Picture Figure 2. CHA Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global CHA Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global CHA Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global CHA Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global CHA Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global CHA Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global CHA Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific CHA Market Size Market Share, 2019-2021

Carbone scientific Ark Pharm Hangzhou Lingeba Technology TCI Wuhan 3B Scientific Corporation HBCChem Sichuan Nanbu Honest and Creditable Science-tech Ltd BePharm Ltd Yolne reagent Aladdin Hunan Hecheng Beijing Yunbang Biosciences Inolex 9Dingchem Chen Hson Holding Limited Yancheng Langde Chemical & Pharmaceutical